Proceeding of 32nd Annual General Meeting of the company held on 16.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Choksi Laboratories Limited held its 32nd Annual General Meeting on 16 September 2025 via video conferencing from 11:00 AM to 11:08 AM, chaired by Managing Director Sunil Choksi. All directors, KMPs, statutory auditor, and secretarial auditor attended through VC. Members approved four resolutions: (1) adoption of the audited balance sheet for FY ending 31 March 2025 (Ordinary), (2) re-appointment of Mrs. Stela Choksi as Whole-Time Director via rotation (Ordinary), (3) re-appointment of Mr. Vyangesh Choksi as Whole-Time Director (Special), and (4) appointment of M/s Surabhi Agrawal & Associates as Secretarial Auditor (Special). Remote e-voting was conducted via CDSL between 13–15 September 2025 with 9 September as the cut-off date. The scrutinizer was given 48 hours to submit the consolidated voting report.
This is a routine procedural filing with no major business surprises — financial statements for FY25 have been adopted, two Choksi family directors (Stela and Vyangesh) continue in their executive roles, and a new secretarial auditor is appointed. No material impact on stock price is expected from this disclosure itself.